美國標準周邊血管器械市場：市場規模、佔有率和趨勢分析（2025-2031 年）

2024 年美國標準周邊血管器械市場價值超過 27 億美元，預計到 2031 年將達到超過 35 億美元。

本報告涵蓋下腔靜脈濾器和取栓器、頸動脈分流器、經頸動脈血管重組血流逆轉系統和支架、診斷和介入性導管、診斷和介入導管導引線、導引鞘、血管閉合裝置和經導管栓塞治療裝置。

雖然其中一些技術也可以用於冠狀動脈手術，但本研究中的所有尺寸和投影都僅適用於周邊手術。

該研究量化了單位銷售、平均售價、市場規模、成長率、手術數量和企業市場占有率。

它還分析了市場促進因素和阻礙因素、併購、投資組合以及醫院、門診設施和辦公室實驗室的競爭格局。

市場概覽

美國的周邊血管治療計畫正不斷轉向動脈和靜脈通路微創治療。

導管導引線、導管、鞘套和栓塞工具在醫院和診所實驗室中用於治療各種疾病。

頸動脈保護和治療可藉助頸動脈分流器和 TCAR 系統實現血流逆轉和支架植入，從而起到神經保護作用；此外，還可使用下腔靜脈濾器和取栓器，用於治療有肺動脈栓塞風險的特定患者。

血管閉合裝置用於經皮後，是實現當日出院和快速下床活動的關鍵。

從整個產品線來看，市場反映了幾個廣泛的主題。

首先，隨著橈動脈入路方案和門診病人復健目標的推進，手術方式已從侵入性縫合逐漸轉向非侵入性血管外縫合。

其次，辦公實驗室的需求不斷成長，使得價格分佈、捆綁銷售和供貨情況變得更加重要。第三，儀器偏好與工作流程有密切關係。

親水性導管和支撐導管可縮短手術時間並提高穿刺成功率。基於塞子和黏合劑的閉合系統因其易用性和良好的安全性而備受青睞。

最後，疾病意識的提高、人口老化以及靜脈護理的持續發展（靜脈疾病歷來診斷不足或治療不足）都對整個市場產生了影響。

市場促進因素

靜脈市場發展。靜脈疾病仍然十分常見，並造成沉重的臨床負擔。美國每年約有60萬肺動脈栓塞，其中大部分是由下肢深層靜脈栓塞症引起的。約79%的肺動脈栓塞患者同時有深層靜脈栓塞症栓塞的觀察，而近端深層靜脈栓塞症形成患者中高達一半也患有肺動脈栓塞。診斷極具挑戰性。在相當一部分病例中，猝死是首發症狀，而高達一半的患者則無症狀。美國每年約有90萬人患有深層靜脈栓塞症。隨著教育、篩檢和治療途徑的擴展，周邊靜脈市場預計將會成長。

影像引導下的靜脈介入治療。血管內超音波的應用對深部靜脈介入治療具有重要意義。由於積極的臨床實踐和針對性的教育，在一些醫療機構中，血管內超音波在深部靜脈手術中的應用率已超過50%。超音波有助於更準確地評估病灶和選擇合適的支架尺寸，並提高同一手術中導管導引線、導管和鞘套的置入次數。

高血管再阻塞率促使患者進行後續干預。約三分之一的患者在球囊血管成形術後會血管再阻塞。在某些適應症中，再次手術支撐了對球囊、導管導引線、支撐導管和栓塞裝置的穩定需求。在支架植入領域，支架內再血管再阻塞可能促使在相關市場進行斑塊動脈粥狀硬化斑塊切除術和使用專用球囊清除斑塊，同時也支撐了標準治療室內對診斷和介入耗材的需求。

治療場所正在不斷發展。越來越多的周邊手術在門診和診所實驗室進行。這些場所需要能夠縮短手術時間、標準化套件並實現當日出院的設備。非侵入性縫合技術可透過減少併發症和縮短恢復時間來滿足這一需求。

市場限制

人們對紫杉醇的謹慎態度也反映在價格上。包衣藥物的複雜程度更高，但2018年的安全訊號和2019年FDA的審查，造成了持續的謹慎情緒，並影響了採購行為。醫院和診所實驗室正在仔細審查其所有周邊設備的價值，即使是標準類別的產品，價格也因此承壓。

診所實驗室的競爭與捆綁銷售。診所實驗室的採購價格通常低於醫院。供應商為爭取優先供貨地位而展開激烈競爭，並經常將鞘套、導管導引線和導管與其他器材捆綁銷售。捆綁銷售會降低平均售價，並對產品組合單一的小型公司構成挑戰。市場力量的集中可能會減緩創新。

股膕動脈段逐漸成熟。隨著股膕動脈區域的治療趨於穩定，其成長速度將放緩，趨向於治療趨勢而非快速擴張。這將影響導絲、導管和閉合器等器械在這些路徑中的通過。

市場和數據覆蓋範圍

定量覆蓋範圍：市場規模、市場佔有率、市場預測、成長率、銷售單位數量、平均售價、手術例數。

定性通報：成長趨勢、市場限制、競爭分析、競爭對手 SWOT 分析、併購、公司簡介和產品系列、FDA 批准和召回（如適用）、顛覆性技術、影響治療方法方案的疾病概況。

時段：基準年 2024 年，預測期間 2025-2031 年，歷史資料 2021-2023 年。

資料來源：對行業領導者的直接訪談、政府醫生和程序資料、監管資料、醫院和診所實驗室輸入、進出口資料、iData Research 內部資料庫。

方法收入以單位乘以平均售價 (ASP) 為模型，並根據裝置量、手術組合、存取方式和設定變化檢驗。

目標市場及區隔

下腔靜脈濾網市場

器械類型：下腔靜脈濾器和下腔靜脈濾器取出裝置。

頸動脈分流術

經頸動脈重組（TCAR）

器械類型：經頸動脈裸金屬支架和TCAR神經保護或血流逆轉系統。

診斷和介入導管市場

器械類型：診斷導管和支撐導管。

診斷和介入導管導引線市場

裝置類型：標準型和親水性。

導引鞘市場

設備類型：標準型和導向型。

血管閉合裝置市場

設備類型：非侵入式與侵入式。

入路：橈動脈和股動脈。

經導管栓塞市場

設備類型：顆粒、線圈、液體、插頭。

入路：橈動脈和股動脈。

競爭分析

2024年，泰爾茂憑藉其導管導引線和血管閉合器械的強勁表現，在美國周邊血管器械市場佔領先地位。該公司在診斷和介入導管以及導引器鞘套也佔領先地位。Terumo Corporation的Glidewire產品在親水性導管領域佔主導地位，該產品將不褪色的鎳鈦合金芯與滲透性的護套相結合。其尖端較柔軟的型號可增強可視性，以適應複雜的解剖結構。該公司透過選擇性地降低導管導引線降價來維持市場佔有率。 2016年，Terumo Corporation收購了Angio-Seal和FemoSeal，鞏固了在美國血管閉合器械市場的領先地位。

波士頓科學公司在2019年收購BTG後，憑藉產品組合的拓展，躍升至第二名。該公司在經經導管栓塞治療裝置處於領先地位，並憑藉VICI系統鞏固了其在靜脈支架領域的地位，而其長期暢銷的Wallstent支架也繼續貢獻著市場佔有率。波士頓科學公司專注於腫瘤治療和深層靜脈栓塞症治療，支撐了對栓塞器械和周邊血管通路耗材的需求。

2024年，雅培血管（Abbott Vascular）佔了第三大市場佔有率，這主要得益於其在大直徑血管閉合領域的統治地位。其縫合式系統，例如StarClosure、Perclose和Prostar XL，利用針頭和結紮來封閉動脈通路。雅培在提高穩定性和易用性的同時，也降低了發炎風險。該公司在2024年幾乎壟斷了大直徑介入性血管閉合手術市場。儘管隨著新型單器械閉合解決方案的進入，雅培的地位可能會面臨壓力，但這些替代方案尚未獲得相同的市場認可。

其他參與企業則在導管、導引線、鞘套、閉塞和栓塞領域競爭，其策略著重於塗層性能、推播性、視覺化以及為多中心團隊和辦公室實驗室提供的服務支援。

科技與臨床趨勢

非侵入性和血管外閉合術的應用日益增加。當日出院計劃傾向於選擇能夠減少併發症並促進早期下床活動的閉合裝置。符合工作流程和安全目標的栓塞式和黏合劑式系統正逐漸佔市場佔有率。臨床指引和健保報銷政策也支持這項轉變。

在條件允許的情況下，先考慮橈動脈入路。橈動脈入路有助於提高患者舒適度並促進早期活動，也適用於門診和診間檢查流程。隨著橈動脈使用率的提高，市場對順應性導引器、親水性導管以及專為橈動脈設計的血管閉合策略的需求也將隨之增加。

親水塗層和導管設計。成功通過取決於摩擦力、扭力和遠端支撐。親水性導管降低阻力。支撐導管可穩定系統並輔助器械輸送。這些特性可縮短手術時間並減少併發症。

採用TCAR路徑：血流逆轉和神經保護是TCAR的核心。為此設計的系統正在拓展頸動脈治療的選擇範圍。

豐富的栓塞治療產品組合。臨床醫師可根據解剖結構和血流狀況，選擇顆粒、彈簧圈、液體和栓塞栓塞劑。輸送系統具有更佳的推送性和控制性，可支援更精準的治療。

護理機構

本報告涵蓋醫院、設有周邊服務的區域醫療機構、門診中心和診所實驗室。不同機構的差異會影響產品選擇、套件標準化和定價。醫院優先考慮庫存充足和能夠處理複雜病例。診所實驗室優先考慮成本、穩定的交付以及適合大量檢測流程的簡易套件。門診中心優先考慮縮短住院時間和可預測的康復，因此支持使用非侵入性閉合裝置和橈動脈入路。

為什麼要寫這份報告？

美國標準周邊血管器材市場中最大且成長最快的機會是什麼？到 2031 年，閉合器械、通路工具、診斷和介入性耗材、栓塞系統、頸動脈分流器和 TCAR 組件將如何各自創造價值？

標準周邊設備市場與美國醫療保健提供者的整體格局有何關係？包括向門診護理的轉變、辦公室實驗室的成長以及預算和人員配備壓力。

未來哪些因素將影響市場格局，包括非侵入性血管外閉合技術的興起、橈動脈優先通訊協定以及依賴精確成像和器械輸送的靜脈通路的持續發展？

預計橈動脈入路和股動脈入路之間的平衡如何？這種選擇將如何影響醫院和門診實驗室對導引鞘、引導鞘套、閉合裝置、親水性導管和止血閥的需求？

栓塞術在創傷、止血和標靶治療中的應用將如何發展？顆粒、彈簧圈、液體和栓塞劑的組合及輸送系統的偏好又會如何改變？

TCAR 在哪些地區將經歷最強勁的成長？神經保護系統的植入將如何促進支架拉出以及滿足治療頸動脈疾病的團隊的服務需求？

iData Research 的「美國標準周邊血管設備市場報告」透過區隔和配置模型、企業市場占有率分析、程序和定價詳情以及將通路和閉合選擇與設備消費聯繫起來的研究來回答這些問題。

利用這份報告來拓展覽類機會、規劃產品藍圖、使捆綁銷售和合約與現場需求保持一致，並設定庫存、服務和培訓目標。

目錄

圖表清單

圖表列表

美國標準周邊血管器械市場概覽

競爭分析

新興市場與技術

市場趨勢

市場趨勢

流程分段

待調查的程式碼

市場區隔

關鍵分析更新

版本歷史記錄

調查方法

全球關稅的影響

美國標準周邊血管器械市場概覽

• 介紹
  • 動脈硬化
  • 周邊動脈疾病（墊片）
• 市場概覽及趨勢分析
  • 複雜周邊血管市場概述及趨勢分析
  • 標準周邊血管市場概述及趨勢分析
• 推動和阻礙因素
• 競爭市佔率分析
• 併購

手術次數

• 介紹
• 程式
  • 綜合標準周邊血管外科
  • 下腔靜脈濾器手術
  • 頸動脈介入手術
  • 血管閉合裝置手術
  • 經導管栓塞術

下腔靜脈濾器和取栓裝置市場

• 介紹
• 市場概覽
• 市場分析與預測
  • 下腔靜脈濾器和取栓裝置市場總規模
  • IVCF 取出裝置市場
• 推動和阻礙因素
• 競爭市佔率分析

頸動脈分流市場

• 介紹
• 市場分析與預測
• 推動和阻礙因素
• 競爭市佔率分析

經頸動脈重組市場

• 介紹
• 市場概覽
• 市場分析與預測
  • 經頸動脈裸金屬支架市場
  • TCAR神經保護系統市場
• 推動和阻礙因素
• 競爭市佔率分析

診斷和介入導管市場

• 介紹
• 市場概覽
• 市場分析與預測
  • 診斷與介入導管總市場
  • 診斷導管市場整體狀況
  • 導管支撐市場
• 推動和阻礙因素
• 競爭市佔率分析

診斷和介入導管導引線市場

• 介紹
• 市場概覽
• 市場分析與預測
  • 診斷與介入導管導引線總市場
  • 標準導管導引線市場
  • 親水導管導引線市場
• 推動和阻礙因素
• 競爭市佔率分析

導引鞘市場

• 介紹
• 市場概覽
• 市場分析與預測
  • 導引鞘市場
  • 標準導引鞘市場
  • 引導導引鞘市場
• 推動和阻礙因素
• 競爭市佔率分析

血管閉合裝置市場

• 介紹
• 市場概覽
  • 血管閉合器械市場概覽（依器械類型分類）
  • 血管閉合裝置市場概覽（依方法分類）
• 市場分析與預測
  • 血管閉合裝置市場整體狀況
  • 血管閉合器械市場（依器械類型分類）
  • 依方法分類的血管閉合裝置市場
• 推動和阻礙因素
• 競爭市佔率分析

經導管栓塞裝置市場

• 介紹
  • 顆粒栓塞
  • 線圈栓塞術
  • 液體栓塞
  • 血管栓塞
• 市場概覽
• 市場分析與預測
  • 經導管栓塞裝置總市場
  • 顆粒栓塞市場整體狀況
  • 整體線圈栓塞市場
  • 液態栓塞市場
  • 栓塞市場
• 推動和阻礙因素
• 競爭市佔率分析

簡稱

The U.S. standard peripheral vascular device market was valued at over $2.7 billion in 2024. The market is expected to reach over $3.5 billion by 2031.

This report suite covers inferior vena cava filters and retrieval devices, carotid shunts, transcarotid arterial revascularization flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices, and transcatheter embolization devices.

While some of these technologies can be used in coronary care, all sizing and forecasts in this study reflect peripheral procedures only.

The research quantifies unit sales, average selling prices, market size, growth rates, procedure numbers, and company shares.

It also analyzes market drivers and limiters, mergers and acquisitions, portfolios, and the competitive landscape across hospitals, ambulatory sites, and office based labs.

Market Overview

Peripheral vascular programs in the United States continue to shift toward minimally invasive care across arterial and venous pathways.

Hospitals and office based labs rely on guidewires, catheters, sheaths, and embolization tools for a wide range of indications.

Carotid protection and treatment are supported by carotid shunts and TCAR systems that allow flow reversal and stenting with neuroprotection. Inferior vena cava filters and retrieval devices address selected patients at risk for pulmonary embolism.

Vascular closure devices are used after percutaneous access and are central to same day discharge and rapid ambulation goals.

Across product lines, the market reflects several broad themes.

First, there is steady movement from invasive or suture-based closure toward non-invasive and extravascular options, in line with radial access protocols and outpatient recovery targets.

Second, demand in office based labs keeps growing, which raises the importance of price corridors, bundles, and consistent supply. Third, device preference is linked to workflow.

Hydrophilic guidewires and supportive catheters shorten case time and improve crossing success. Plug-based and adhesive-based closure systems are valued for ease of use and favorable safety profiles.

Finally, the overall market is influenced by disease awareness, aging demographics, and the continued development of venous treatments that were historically underdiagnosed or undertreated.

Market Drivers

Venous market development. Venous disease remains common and is a major clinical burden. The United States records about 600,000 pulmonary embolism cases per year. Most originate from deep vein thrombosis in the legs. About 79 percent of patients who present with pulmonary embolism show evidence of deep vein thrombosis, and pulmonary embolism occurs in up to half of patients with proximal deep vein thrombosis. Diagnosis can be difficult. Sudden death is the first symptom in a meaningful share of cases, and up to half of patients have no symptoms. About 900,000 people in the United States are affected by deep vein thrombosis each year. As education, screening, and treatment pathways expand, the venous segment of the peripheral market is expected to grow.

Imaging-guided venous interventions. Adoption of intravascular ultrasound is closely linked to deep venous work. Following positive clinical experience and targeted education, penetration of intravascular ultrasound in deep venous procedures already exceeds 50 percent in some programs. Wider use of intravascular ultrasound supports more accurate lesion assessment and stent sizing, which lifts pull-through for guidewires, catheters, and sheaths within the same case.

High restenosis rates drive follow-up intervention. Roughly one third of patients experience re-narrowing after balloon angioplasty. Repeat procedures support steady demand for balloons, guidewires, support catheters, and embolization devices in specific indications. In stented segments, in-stent restenosis can lead to plaque removal with atherectomy or specialty balloons in adjacent markets, and it also supports demand for diagnostic and interventional consumables within the standard suite.

Site of care evolution. More peripheral cases are performed in ambulatory settings and office based labs. These sites prize devices that shorten procedure time, standardize kits, and enable same day discharge. Non-invasive closure technologies fit this need by reducing complications and recovery time.

Market Limiters

Paclitaxel caution spills over to price sensitivity. Although drug-coated products are detailed more deeply in complex suites, the 2018 safety signal and the 2019 FDA review created long-lasting caution that influences purchasing behavior. Hospitals and office based labs scrutinize value across the basket of peripheral tools, which adds pressure to pricing in standard categories as well.

Competition and bundling in office based labs. Office based labs buy at prices that are already below hospital levels. Vendors compete hard for preferred supplier status and often bundle sheaths, guidewires, and catheters with other devices. Bundles lower average selling prices and can challenge smaller firms with narrower portfolios. If market power concentrates, innovation can slow.

Maturing femoral-popliteal segment. As treatment practices become stable in the femoral-popliteal region, growth moderates toward procedural trends rather than rapid expansion. This affects pull-through for wires, catheters, and closure products used in those pathways.

Market Coverage and Data Scope

Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, average selling prices, and procedure numbers.

Qualitative coverage. Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA clearances and recalls where relevant, disruptive technologies, and disease overviews that influence therapy selection.

Time frame. Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2023.

Data sources. Primary interviews with industry leaders, government physician and procedure data, regulatory data, hospital and office based lab inputs, import and export data, and the iData Research internal database.

Method note. Revenues are modeled as units multiplied by ASP and validated against installed base, procedure mix, access approach, and setting shifts.

Markets Covered and Segmentation

Inferior Vena Cava Filter Market

Device type. IVC filter and IVC filter retrieval device.

Carotid Shunt

Transcarotid Artery Revascularization (TCAR)

Device type. Transcarotid bare-metal stent and TCAR neuroprotection or flow reversal system.

Diagnostic and Interventional Catheter Market

Device type. Diagnostic catheter and support catheter.

Diagnostic and Interventional Guidewire Market

Device type. Standard and hydrophilic.

Introducer Sheath Market

Device type. Standard and guiding.

Vascular Closure Device Market

Device type. Non-invasive and invasive.

Approach. Radial and femoral.

Transcatheter Embolization Market

Device type. Particle, coil, liquid, and plug.

Approach. Radial and femoral.

Competitive Analysis

Terumo led the U.S. peripheral vascular device market in 2024 on the strength of guidewires and vascular closure devices. The company also held top positions in diagnostic and interventional catheters and in introducer sheaths. Terumo dominated the hydrophilic guidewire segment with Glidewire products that combine a kink-resistant nitinol core and a radiopaque jacket. Variants with softer tips and enhanced visibility serve complex anatomy. The company has used selective price reductions on guidewires to protect share. Terumo secured leadership in the U.S. closure device market after acquiring Angio-Seal and FemoSeal in 2016

Boston Scientific ranked second after expanding its portfolio with the 2019 acquisition of BTG. The company leads in transcatheter embolization devices and holds positions in venous stents with the VICI system, while the long-standing Wallstent continues to contribute share. Boston Scientific has focused on oncology and deep vein thrombosis care, which supports demand for embolization tools and peripheral access consumables.

Abbott Vascular held the third-largest share in 2024, driven by dominance in large-bore vascular closure. Suture-mediated systems such as StarClose, Perclose, and ProStar XL seal arterial access with needles and knots. Abbott has improved stability and ease of use while reducing inflammation risk. The company held a near monopoly in large-bore invasive closure in 2024. Its position may face pressure as newer single-device closure solutions enter the market, but those alternatives have not yet reached the same traction.

Other participants compete across catheters, wires, sheaths, closure, and embolization with strategies that focus on coating performance, pushability, visualization, and service support for multi-site groups and office based labs.

Technology and Practice Trends

Non-invasive and extravascular closure gains. Programs that target same day discharge favor closure devices that reduce complications and allow faster ambulation. Plug-based and adhesive-based systems are gaining share where they fit workflow and safety goals. Clinical guidance and reimbursement support this shift.

Radial first where appropriate. Radial access supports patient comfort and earlier mobilization. It also aligns with outpatient and office based lab pathways. As radial use grows, demand shifts toward compatible introducers, hydrophilic guidewires, and closure strategies designed for radial arteries.

Hydrophilic coatings and supportive catheter design. Crossing success depends on friction, torque, and distal support. Hydrophilic guidewires reduce resistance. Support catheters stabilize the system and aid device delivery. These features reduce case time and limit complications.

TCAR pathway adoption. Flow reversal and neuroprotection are central to TCAR. Systems designed for this approach are expanding the options for carotid treatment.

Embolization portfolio breadth. Physicians choose among particles, coils, liquids, and plugs based on anatomy and flow. Delivery systems are improving in pushability and control, which supports more targeted therapy.

Care Settings

The report covers hospitals, community sites with peripheral programs, ambulatory centers, and office based labs. Site differences affect product choice, kit standardization, and price. Hospitals value broad inventory and support for complex cases. Office based labs focus on cost, consistent delivery, and simple kits that match high-volume protocols. Ambulatory centers target short stays and predictable recovery, which supports non-invasive closure devices and radial access where indicated.

Why This Report

Where is the largest and fastest growing opportunity within the U.S. standard peripheral vascular device market, and how do closure devices, access tools, diagnostic and interventional consumables, embolization systems, carotid shunts, and TCAR components each contribute to value through 2031.

How does the standard peripheral device market relate to the broader U.S. provider landscape, including the shift to outpatient care, growth of office based labs, and pressure on budgets and staffing.

What forces will shape the market going forward, including the rise of non-invasive and extravascular closure, radial first protocols, and the continued development of venous pathways that rely on accurate imaging and device delivery.

What is the expected balance between radial and femoral access, and how will this choice change demand for introducer sheaths, guiding sheaths, closure devices, hydrophilic guidewires, and hemostasis valves across hospitals and office based labs.

How will embolization usage evolve across trauma, bleeding control, and targeted therapy, and what does this mean for the mix of particles, coils, liquids, and plugs, as well as delivery system preferences.

Where will TCAR see the most consistent growth, and how will neuroprotection system placements drive stent pull-through and service requirements for teams that manage carotid disease.

The U.S. standard peripheral vascular device market report from iData Research answers these questions with segment and setting models, company share analysis, procedure and pricing detail, and coverage that links access and closure choices to device consumption.

Use it to size opportunities by category, plan product roadmaps, align bundles and contracts with site needs, and set targets for inventory, service, and training.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

U.S. Standard Peripheral Vascular Device Market Overview

Competitive Analysis

Emerging Markets And Technologies

Market Trends

Market Developments

Procedure Segmentation

Procedure Codes Investigated

Market Segmentation

Key Analysis Updates

Version History

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

U.S. Standard Peripheral Vascular Device Market Overview

• 3.1 Introduction
  • 3.1.1 Atherosclerosis
  • 3.1.2 Peripheral Arterial Disease (Pad)
• 3.2 Market Overview & Trend Analysis
  • 3.2.1 Complex Peripheral Vascular Market Overview & Trend Analysis
  • 3.2.2 Standard Peripheral Vascular Market Overview & Trend Analysis
• 3.3 Drivers And Limiters
  • 3.3.1 Market Drivers
  • 3.3.2 Market Limiters
• 3.4 Competitive Market Share Analysis
• 3.5 Mergers And Acquisitions

Procedure Numbers

• 4.1 Introduction
• 4.2 Procedures
  • 4.2.1 Total Standard Peripheral Vascular Procedures
  • 4.2.2 Inferior Vena Cava Filter Procedures
    • 4.2.2.1 Inferior Vena Cava Filter Procedures By Procedure Type
    • 4.2.2.1.1 Ivcf Placement Procedures By Device Type
  • 4.2.3 Carotid Intervention Procedures
    • 4.2.3.1 Carotid Intervention Procedures By Procedure Type
  • 4.2.4 Vascular Closure Device Procedures
    • 4.2.4.1 Vascular Closure Device Procedures By Device Type
    • 4.2.4.1.1 Invasive Vascular Closure Procedures By Device Size
    • 4.2.4.2 Vascular Closure Procedures By Approach
  • 4.2.5 Transcatheter Embolization Procedures
    • 4.2.5.1 Transcatheter Embolization Procedures By Device Type
    • 4.2.5.1.1 Transcatheter Particle Embolization Procedures By Device Type
    • 4.2.5.1.2 Transcatheter Coil Embolization Procedures By Device Type

Inferior Vena Cava Filter & Retrieval Device Market

• 5.1 Introduction
• 5.2 Market Overview
• 5.3 Market Analysis And Forecast
  • 5.3.1 Total Inferior Vena Cava Filter & Retrieval Device Market
    • 5.3.1.1 Retrievable Ivcf Market
    • 5.3.1.2 Permanent Ivcf Market
  • 5.3.2 Ivcf Retrieval Device Market
• 5.4 Drivers And Limiters
  • 5.4.1 Market Drivers
  • 5.4.2 Market Limiters
• 5.5 Competitive Market Share Analysis

Carotid Shunt Market

• 6.1 Introduction
• 6.2 Market Analysis And Forecast
• 6.3 Drivers And Limiters
  • 6.3.1 Market Drivers
  • 6.3.2 Market Limiters
• 6.4 Competitive Market Share Analysis

Transcarotid Artery Revascularization Market

• 7.1 Introduction
• 7.2 Market Overview
• 7.3 Market Analysis And Forecast
  • 7.3.1 Transcarotid Bare-Metal Stent Market
  • 7.3.2 Tcar Neuroprotection System Market
• 7.4 Drivers And Limiters
  • 7.4.1 Market Drivers
  • 7.4.2 Market Limiters
• 7.5 Competitive Market Share Analysis

Diagnostic & Interventional Catheter Market

• 8.1 Introduction
• 8.2 Market Overview
• 8.3 Market Analysis And Forecast
  • 8.3.1 Total Diagnostic And Interventional Catheter Market
  • 8.3.2 Total Diagnostic Catheter Market
    • 8.3.2.1 Standard Diagnostic Catheter Market
    • 8.3.2.2 Hydrophilic Diagnostic Catheter Market
  • 8.3.3 Support Catheter Market
• 8.4 Drivers And Limiters
  • 8.4.1 Market Drivers
  • 8.4.2 Market Limiters
• 8.5 Competitive Market Share Analysis

Diagnostic & Interventional Guidewire Market

• 9.1 Introduction
• 9.2 Market Overview
• 9.3 Market Analysis And Forecast
  • 9.3.1 Total Diagnostic And Interventional Guidewire Market
  • 9.3.2 Standard Guidewire Market
  • 9.3.3 Hydrophilic Guidewire Market
• 9.4 Drivers And Limiters
  • 9.4.1 Market Drivers
  • 9.4.2 Market Limiters
• 9.5 Competitive Market Share Analysis

Introducer Sheath Market

• 10.1 Introduction
• 10.2 Market Overview
• 10.3 Market Analysis And Forecast
  • 10.3.1 Total Introducer Sheath Market
  • 10.3.2 Standard Introducer Sheath Market
  • 10.3.3 Guiding Introducer Sheath Market
• 10.4 Drivers And Limiters
  • 10.4.1 Market Drivers
  • 10.4.2 Market Limiters
• 10.5 Competitive Market Share Analysis

Vascular Closure Device Market

• 11.1 Introduction
• 11.2 Market Overview
  • 11.2.1 Vascular Closure Device Market Overview By Device Type
  • 11.2.2 Vascular Closure Device Market Overview By Approach
• 11.3 Market Analysis And Forecast
  • 11.3.1 Total Vascular Closure Device Market
  • 11.3.2 Vascular Closure Device Market By Device Type
    • 11.3.2.1 Non-Invasive Vascular Closure Device Market
    • 11.3.2.2 Total Invasive Vascular Closure Device Market
    • 11.3.2.2.1 Small-Bore Invasive Vcd Market
    • 11.3.2.2.2 Large-Bore Invasive Vcd Market
  • 11.3.3 Vascular Closure Device Market By Approach
    • 11.3.3.1 Radial Vcd Market
    • 11.3.3.2 Femoral Vcd Market
• 11.4 Drivers And Limiters
  • 11.4.1 Market Drivers
  • 11.4.2 Market Limiters
• 11.5 Competitive Market Share Analysis

Transcatheter Embolization Device Market

• 12.1 Introduction
  • 12.1.1 Particle Embolics
  • 12.1.2 Coil Embolics
  • 12.1.3 Liquid Embolics
  • 12.1.4 Vascular Plugs
• 12.2 Market Overview
• 12.3 Market Analysis And Forecast
  • 12.3.1 Total Transcatheter Embolization Device Market
  • 12.3.2 Total Particle Embolization Market
    • 12.3.2.1 Pva Particle Embolization Market
    • 12.3.2.2 Microsphere Particle Embolization Market
    • 12.3.2.3 Drug-Eluting Particle Embolization Market
    • 12.3.2.4 Radioactive Particle Embolization Market
  • 12.3.3 Total Coil Embolization Market
    • 12.3.3.1 Pushable Coil Market
    • 12.3.3.2 Detachable Coil Market
  • 12.3.4 Liquid Embolization Market
  • 12.3.5 Plug Embolization Market
• 12.4 Drivers And Limiters
  • 12.4.1 Market Drivers
  • 12.4.2 Market Limiters
• 12.5 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 1-1: Standard Peripheral Vascular Device Market by Segment, U.S., 2024 - 2031
• Chart 1-2: Standard Peripheral Vascular Device Market Overview, U.S., 2024 & 2031
• Chart 3-1: Complex Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031
• Chart 3-2: Standard Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031
• Chart 3-3: Leading Competitors, Standard Peripheral Vascular Device Market, U.S., 2024
• Chart 4-1: Standard Peripheral Vascular Procedures by Segment, U.S., 2021 - 2031
• Chart 5-1: Inferior Vena Cava Filter & Retrieval Device Market by Segment, U.S., 2021 - 2031
• Chart 5-2: Leading Competitors, Inferior Vena Cava Filter & Retrieval Device Market, U.S., 2024
• Chart 6-1: Carotid Shunt Market, U.S., 2021 - 2031
• Chart 6-2: Leading Competitors, Carotid Shunt Market, U.S., 2024
• Chart 7-1: Transcarotid Artery Revascularization Market by Segment, U.S., 2021 - 2031
• Chart 8-1: Diagnostic & Interventional Catheter Market by Segment, U.S., 2021 - 2031
• Chart 8-2: Leading Competitors, Diagnostic & Interventional Catheter Market, U.S., 2024
• Chart 9-1: Diagnostic & Interventional Guidewire Market by Segment, U.S., 2021 - 2031
• Chart 9-2: Leading Competitors, Diagnostic & Interventional Guidewire Market, U.S., 2024
• Chart 10-1: Introducer Sheath Market by Segment, U.S., 2021 - 2031
• Chart 10-2: Leading Competitors, Introducer Sheath Market, U.S., 2024
• Chart 11-1: Vascular Closure Device Market by Device Type, U.S., 2021 - 2031
• Chart 11-2: Vascular Closure Device Market by Approach, U.S., 2021 - 2031
• Chart 11-3: Leading Competitors, Vascular Closure Device Market, U.S., 2024
• Chart 12-1: Transcatheter Embolization Device Market by Segment, U.S., 2021 - 2031
• Chart 12-2: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2024

LIST OF FIGURES

• Figure 1-1: Standard Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2024 (1 of 2)
• Figure 1-2: Standard Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2024 (2 of 2)
• Figure 1-3: Companies Researched in This Report (1 of 2)
• Figure 1-4: Companies Researched in This Report (2 of 2)
• Figure 1-5: Factors Impacting the Standard Peripheral Vascular Device Market by Segment, U.S. (1 of 2)
• Figure 1-6: Factors Impacting the Standard Peripheral Vascular Device Market by Segment, U.S. (2 of 2)
• Figure 1-7: Recent Events in the Peripheral Vascular Device Market, U.S., 2019 - 2025
• Figure 1-8: Peripheral Vascular Device Procedures Covered by Indication (1 of 3)
• Figure 1-9: Peripheral Vascular Device Procedures Covered by Indication (2 of 3)
• Figure 1-10: Peripheral Vascular Device Procedures Covered by Indication (3 of 3)
• Figure 1-11: Standard Peripheral Vascular Device Procedures Covered by Device Type
• Figure 1-12: Complex Peripheral Vascular Device Procedures Covered by Device Type (1 of 4)
• Figure 1-13: Complex Peripheral Vascular Device Procedures Covered by Device Type (2 of 4)
• Figure 1-14: Complex Peripheral Vascular Device Procedures Covered by Device Type (3 of 4)
• Figure 1-15: Complex Peripheral Vascular Device Procedures Covered by Device Type (4 of 4)
• Figure 1-16: Procedure Codes Investigated
• Figure 1-17: Standard Peripheral Vascular Device Market Segmentation (1 of 2)
• Figure 1-18: Standard Peripheral Vascular Device Market Segmentation (2 of 2)
• Figure 1-19: Complex Peripheral Vascular Device Market Segmentation (1 of 4)
• Figure 1-20: Complex Peripheral Vascular Device Market Segmentation (2 of 4)
• Figure 1-21: Complex Peripheral Vascular Device Market Segmentation (3 of 4)
• Figure 1-22: Complex Peripheral Vascular Device Market Segmentation (4 of 4)
• Figure 1-23: Key Analysis Updates
• Figure 1-24: Version History
• Figure 3-1: Complex Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 2)
• Figure 3-2: Complex Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 2)
• Figure 3-3: Standard Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 2)
• Figure 3-4: Standard Peripheral Vascular Device Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 2)
• Figure 3-5: Leading Competitors, Standard Peripheral Vascular Device Market, U.S., 2024 (1 of 2)
• Figure 3-6: Leading Competitors, Standard Peripheral Vascular Device Market, U.S., 2024 (2 of 2)
• Figure 4-1: Procedure Codes Investigated, U.S., 2024
• Figure 4-2: Standard Peripheral Vascular Procedures by Segment, U.S., 2021 - 2031
• Figure 4-3: Inferior Vena Cava Filter Procedures by Procedure Type, U.S., 2021 - 2031
• Figure 4-4: IVCF Placement Procedures by Device Type, U.S., 2021 - 2031
• Figure 4-5: Carotid Intervention Procedures by Procedure Type, U.S., 2021 - 2031
• Figure 4-6: Vascular Closure Device Procedures by Device Type, U.S., 2021 - 2031
• Figure 4-7: Invasive Vascular Closure Procedures by Device Size, U.S., 2021 - 2031
• Figure 4-8: Vascular Closure Procedures by Approach, U.S., 2021 - 2031
• Figure 4-9: Transcatheter Embolization Procedures by Device Type, U.S., 2021 - 2031
• Figure 4-10: Transcatheter Particle Embolization Procedures by Device Type, U.S., 2021 - 2031
• Figure 4-11: Transcatheter Coil Embolization Procedures by Device Type, U.S., 2021 - 2031
• Figure 5-1: Inferior Vena Cava Filter & Retrieval Device Market by Segment, U.S., 2021 - 2031 (US$M)
• Figure 5-2: Retrievable IVCF Market, U.S., 2021 - 2031
• Figure 5-3: Permanent IVCF Market, U.S., 2021 - 2031
• Figure 5-4: IVCF Retrieval Device Market, U.S., 2021 - 2031
• Figure 5-5: Leading Competitors, Inferior Vena Cava Filter & Retrieval Device Market, U.S., 2024
• Figure 6-1: Carotid Shunt Market, U.S., 2021 - 2031
• Figure 6-2: Leading Competitors, Carotid Shunt Market, U.S., 2024
• Figure 7-1: Transcarotid Artery Revascularization Market by Segment, U.S., 2021 - 2031 (US$M)
• Figure 7-2: Transcarotid Bare-Metal Stent Market, U.S., 2021 - 2031
• Figure 7-3: TCAR Neuroprotection System Market, U.S., 2021 - 2031
• Figure 7-4: Leading Competitors, Transcarotid Artery Revascularization Market, U.S., 2024
• Figure 8-1: Diagnostic & Interventional Catheter Market by Segment, U.S., 2021 - 2031 (US$M)
• Figure 8-2: Total Diagnostic & Interventional Catheter Market, U.S., 2021 - 2031
• Figure 8-3: Diagnostic Catheter Market by Segment, U.S., 2021 - 2031 (US$M)
• Figure 8-4: Total Diagnostic Catheter Market, U.S., 2021 - 2031
• Figure 8-5: Standard Diagnostic Catheter Market, U.S., 2021 - 2031
• Figure 8-6: Hydrophilic Diagnostic Catheter Market, U.S., 2021 - 2031
• Figure 8-7: Support Catheter Market, U.S., 2021 - 2031
• Figure 8-8: Leading Competitors, Diagnostic & Interventional Catheter Market, U.S., 2024
• Figure 9-1: Diagnostic & Interventional Guidewire Market by Segment, U.S., 2021 - 2031 (US$M)
• Figure 9-2: Total Diagnostic & Interventional Guidewire Market, U.S., 2021 - 2031
• Figure 9-3: Standard Guidewire Market, U.S., 2021 - 2031
• Figure 9-4: Hydrophilic Guidewire Market, U.S., 2021 - 2031
• Figure 9-5: Leading Competitors, Diagnostic & Interventional Guidewire Market, U.S., 2024
• Figure 10-1: Introducer Sheath Market by Segment, U.S., 2021 - 2031 (US$M)
• Figure 10-2: Total Introducer Sheath Market, U.S., 2021 - 2031
• Figure 10-3: Standard Introducer Sheath Market, U.S., 2021 - 2031
• Figure 10-4: Guiding Introducer Sheath Market, U.S., 2021 - 2031
• Figure 10-5: Leading Competitors, Introducer Sheath Market, U.S., 2024
• Figure 11-1: Vascular Closure Device Market by Device Type, U.S., 2021 - 2031 (US$M)
• Figure 11-2: Vascular Closure Device Market by Approach, U.S., 2021 - 2031 (US$M)
• Figure 11-3: Total Vascular Closure Device Market, U.S., 2021 - 2031
• Figure 11-4: Non-Invasive VCD Market, U.S., 2021 - 2031
• Figure 11-5: Invasive Vascular Closure Device Market by Application, U.S., 2021 - 2031 (US$M)
• Figure 11-6: Total Invasive Vascular Closure Device Market, U.S., 2021 - 2031
• Figure 11-7: Small-Bore Invasive VCD Market, U.S., 2021 - 2031
• Figure 11-8: Large-Bore Invasive VCD Market, U.S., 2021 - 2031
• Figure 11-9: Radial VCD Market, U.S., 2021 - 2031
• Figure 11-10: Femoral VCD Market, U.S., 2021 - 2031
• Figure 11-11: Leading Competitors by Device Type, Vascular Closure Device Market, U.S., 2024
• Figure 11-12: Leading Competitors, Invasive Vascular Closure Device Market, U.S., 2024
• Figure 11-13: Leading Competitors by Approach, Vascular Closure Device Market, U.S., 2024
• Figure 12-1: Transcatheter Embolization Device Market by Segment, U.S., 2021 - 2031 (US$M)
• Figure 12-2: Total Transcatheter Embolization Device Market, U.S., 2021 - 2031
• Figure 12-3: Particle Embolization Market by Segment, U.S., 2021 - 2031 (US$M)
• Figure 12-4: Total Embolization Particle Market, U.S., 2021 - 2031
• Figure 12-5: PVA Particle Embolization Market, U.S., 2021 - 2031
• Figure 12-6: Microsphere Particle Embolization Market, U.S., 2021 - 2031
• Figure 12-7: Drug-Eluting Particle Embolization Market, U.S., 2021 - 2031
• Figure 12-8: Radioactive Particle Embolization Market, U.S., 2021 - 2031
• Figure 12-9: Coil Embolization Market by Segment, U.S., 2021 - 2031 (US$M)
• Figure 12-10: Total Coil Embolization Market, U.S., 2021 - 2031
• Figure 12-11: Pushable Coil Market, U.S., 2021 - 2031
• Figure 12-12: Detachable Coil Market, U.S., 2021 - 2031
• Figure 12-13: Liquid Embolization Market, U.S., 2021 - 2031
• Figure 12-14: Plug Embolization Market, U.S., 2021 - 2031
• Figure 12-15: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2024
• Figure 12-16: Leading Competitors, Particle Embolization Market, U.S., 2024
• Figure 12-17: Leading Competitors, Coil Embolization Market, U.S., 2024